Austria vs Costa Rica: Previously treated cases tested for RR-/MDR-TB
Austria
61.0%
in 2024
Costa Rica
62.0%
in 2024
Austria rank
136th
Costa Rica rank
135th
Previously treated cases tested for RR-/MDR-TB over time
- Austria
- Costa Rica
How they compare
Costa Rica currently reports 62.0% against 61.0% in Austria, a difference of 1.0%.
The two have swapped places 7 times across 15 shared years of data; in 2005 it was Austria ahead.
Austria ranks 136th and Costa Rica ranks 135th of 180 countries.
Austria has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Austria | Costa Rica | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 61.5% | 51.1% | 10.4% | Austria |
| 2010s | 59.0% | 39.3% | 19.7% | Austria |
| 2020s | 57.5% | 54.8% | 2.8% | Austria |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Austria or Costa Rica?
- Costa Rica, at 62.0% against 61.0% in Austria as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Austria and Costa Rica?
- 1.0%, with Costa Rica ahead.
- How many years of comparable data are there for Austria and Costa Rica?
- 15 years are reported by both, from 2005 to 2024.
- How do Austria and Costa Rica rank globally for previously treated cases tested for rr-/mdr-tb?
- Austria ranks 136th and Costa Rica ranks 135th of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.